Newborn screening for epilepsy in sight through the discovery of novel disease biomarkers ...Middle East

- News
Newborn screening for epilepsy in sight through the discovery of novel disease biomarkers
The door has finally opened on screening newborn babies for pyridoxine-dependent epilepsy (PDE), a severe inherited metabolic disorder. This screening promises to enable better and earlier treatment of the disease. To identify new biomarkers that can be used in the newborn screening protocol, also known as the neonatal heel prick, researchers at the Radboud University Medical Center joined forces with scientists at the Radboud University's FELIX laser laboratory.

Hence then, the article about newborn screening for epilepsy in sight through the discovery of novel disease biomarkers was published today ( ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Newborn screening for epilepsy in sight through the discovery of novel disease biomarkers )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News